r/ScientificNutrition • u/Caiomhin77 • 5h ago
Scholarly Article A Delphi consensus-based guideline for the implementation of therapeutic carbohydrate reduction in metabolic disorders
r/ScientificNutrition • u/Caiomhin77 • 5h ago
r/ScientificNutrition • u/flowersandmtns • 12h ago
Ageing is a complex process influenced by modifiable factors such as diet, which may accelerate or decelerate physiological decline. While chronological age increases uniformly, biological ageing varies between individuals, reflecting differences in health status and the resilience of biological systems. The Klemera-Doubal Method (KDM), a composite biomarker-based index often used as an estimate of biological age, has been associated with morbidity and mortality in large cohorts. This study examined whether dietary manipulation of protein source and macronutrient composition affects KDM estimates in older adults. We analysed data from the Nutrition for Healthy Living study, a 2 × 2 factorial dietary intervention trial involving 104 participants aged 65–75 years. Participants were randomised to one of four diets: omnivorous/high-fat (OHF), omnivorous/high-carbohydrate (OHC), semi-vegetarian/high-fat (VHF) or semi-vegetarian/high-carbohydrate (VHC). KDM-derived δAge (the difference between KDM- and chronological-age) was calculated before and after a 4-week intervention. The OHF group, most like participants' baseline diets, showed no meaningful change in δAge. Compared to OHF, participants in the OHC group showed a significant reduction in δAge. The VHF and VHC groups showed similar reductions in δAge, relative to OHF, though not all reached statistical significance. KDM-derived δAge appears responsive to dietary change within 4 weeks and may offer a useful proxy for evaluating shifts in physiological status. Caution is warranted in interpreting such changes as evidence of biological age reversal as observed shifts may reflect acute physiological responsiveness to dietary inputs rather than altered ageing trajectories. Longer-term treatment would be needed to assess changes in age-related disease risks.
r/ScientificNutrition • u/Acrobatic_Golf9325 • 19h ago
PMID: 43060231
Background: Low-calorie sweeteners (LCS) are consumed as sugar substitutes and may alter gut microbial composition. Their effects on microbial functional pathways and cardiometabolic physiology in humans remain poorly understood, particularly among individuals with overweight.
Methods: We conducted a secondary analysis of an 8-week, single-arm pre/post intervention involving eight overweight young adult women who consumed sucralose- and acesulfame-potassium-sweetened Diet Pepsi three times daily. Shotgun metagenomic sequencing of stool samples was used to profile microbial functional pathways with HUMAnN2. Multivariable linear mixed models (MaAsLin2) assessed associations between pathways and metabolic biomarkers. We hierarchically clustered nominally significant pathways into six representative groups and calculated Spearman correlations with interleukin-6 (IL-6), leptin, and HOMA-IR. P values were adjusted using the Benjamini-Hochberg false discovery rate (FDR) procedure. Biomarkers were measured using clinical chemistry and immunoassays.
Results: MaAsLin2 identified 33 microbial pathways nominally associated with the intervention (exploratory FDR ≤ 0.25); one pathway (PWY-5104) also met the conventional FDR ≤ 0.10 threshold. Eighteen pathways were upregulated and 15 downregulated, with log fold changes ranging from -2.47 to 3.18. The 33 pathways were grouped into six functional clusters. L-alanine biosynthesis (PWY0-1061) was positively correlated with circulating IL-6 (ρ = 0.74; q < 0.01). Phosphopantothenate biosynthesis I (PANTO-PWY) was not significantly correlated with IL-6 (ρ = -0.46; q = 0.22).
Conclusion: Gut microbial functional analysis identified a positive association between L-alanine biosynthesis and circulating IL-6. This finding complements previously reported taxonomic shifts in this cohort and suggests a potential relationship between LCS consumption, microbial function, and host inflammatory signaling.
r/ScientificNutrition • u/Caiomhin77 • 13h ago
r/ScientificNutrition • u/AdeptRice3646 • 13h ago
This is my frugivore starchivore food pyramid plan based on human anatomy, and research into longevity blue zones like Okinawa and the Mediterranean - (The fact that humans have flat teeth and are 98% related to chimpanzees who eat 55% of their diet calories from fruit and the fact that most humans are born with between 8 to 20 amylase genes for digesting starches, no rumnant style stomach chambers for digesting a mass amount of leaves or vegetables and the fact that human taste buds are not designed to desire raw leaves but the taste of sweet fruit legumes edible cooked tubers seeds and grains, Biblical evidence that we are designed for fruits and seeds (fruits, legumes, nuts and seeds, grains) the fact of the seasonality of different fruit nuts and seeds, the fact that most of the dense tribal populations lived in or near the equatorial regions on earth, the fact that canned legumes dried fruit can be stored for years as additional staple foods, + witnessed evidence from Okinawa elders telling straightforward what they ate and grew and harvested everyday back 80 years ago (soybeans legumes and sweet potatoes as their main meals and staple crops) , digestibily of different foods, and research into electrolytes like essential potassium and sodium for optimal brain nerve and hydration function.
r/ScientificNutrition • u/Icy-Performance-5313 • 1d ago
As in, is it digestible and can we digest the carbohydrates and grains in them well?
r/ScientificNutrition • u/Dizzy-Savings-1962 • 3d ago
https://doi.org/10.1016/j.ijcha.2026.102027
Impact of glycemic status on coronary lesion characteristics in patients with symptomatic coronary artery disease

We already know that type 2 diabetes wreaks havoc on blood vessels, but mounting clinical data shows that even mild blood sugar elevations below the diagnostic threshold start damaging the cardiovascular system long before clinical presentation. Chronic hyperglycemia drives endothelial dysfunction, oxidative stress, and vascular inflammation, setting the stage for advanced atherosclerotic plaque development. Despite this well-documented risk gradient, clinicians often struggle to fully capture vascular disease severity using standard diagnostic markers alone. To address this gap, this study investigated how varying blood sugar levels impact specific coronary lesion characteristics in symptomatic patients evaluated via coronary computed tomography angiography.
The analysis tracked 184 patients and 247 coronary lesions, stratifying participants into euglycemic, prediabetic, and diabetic cohorts based on their glycated hemoglobin values. Results show that prediabetic and diabetic patients harbor significantly longer coronary lesions compared to euglycemic peers, measuring 29.5 mm versus 24.8 mm (p = 0.025) and 30.1 mm versus 24.8 mm (p = 0.005) respectively. Diabetic individuals also demonstrated massively expanded total lipid-rich plaque volumes at 62.5 mm3 compared to 41.9 mm3 (p < 0.001) and total fibrotic plaque volumes at 55.7 mm3 compared to 29.3 mm3 (p = 0.004) relative to euglycemic patients. In multivariable adjusted logistic regression models, both prediabetes and diabetes showed a significant independent association with predominantly non-calcified plaques, yielding odds ratios of OR 2.124 (95% CI 1.016 to 4.437, p = 0.045) and OR 2.505 (95% CI 1.029 to 6.098, p = 0.043) respectively.
Sample size: 184 patients and 247 coronary lesions
Duration: Retrospective analysis utilizing imaging databases spanning from 2011 to 2016
Measurement tools: 128-slice and 192-slice dual source CT systems (Siemens Healthineers) combined with a specialized semi-automatic software prototype (Coronary Plaque Analysis 2.0.3, Syngo.via VA30)
Controls: Stratified cohorts based on HbA1c levels (Euglycemia < 5.7%, Prediabetes 5.7 to 6.4%, Diabetes >= 6.5%)
Metabolic ward: No
Blinding: Yes, culprit lesions were independently evaluated by two blinded observers
Washout period: None (observational retrospective design)
Coronary lesion length was significantly greater in prediabetics (29.5 mm, p = 0.025) and diabetics (30.1 mm, p = 0.005) versus euglycemics (24.8 mm).
Total lipid-rich plaque volume was significantly higher in diabetics (62.5 mm3) compared to euglycemics (41.9 mm3, p < 0.001).
Total fibrotic plaque volume was significantly higher in diabetics (55.7 mm3) compared to euglycemics (29.3 mm3, p = 0.004).
Prediabetes was independently associated with predominantly non-calcified plaques after multivariable adjustment (OR 2.124, 95% CI 1.016 to 4.437, p = 0.045).
Diabetes showed a similar independent association with predominantly non-calcified plaques (OR 2.505, 95% CI 1.029 to 6.098, p = 0.043).
Glycated hemoglobin demonstrated a significant independent association with predominantly non-calcified plaques in GEE modeling accounting for clustering (B = 0.654, SE = 0.2892, 95% CI [0.87 to 1.221], p = 0.024).
Total calcified plaque volume showed no significant differences across groups (93.1 mm3 vs 110.9 mm3 vs 83.4 mm3, p = 0.084).
Retrospective cross-sectional design prevents establishing direct temporal causation or tracking individual plaque progression over time.
The diabetic subgroup sample size was relatively small at 27 patients.
Study population consisted exclusively of symptomatic individuals with pre-existing severe coronary artery disease, introducing selection bias toward higher baseline cardiovascular risk.
Clinical outcome data and patient-oriented hard endpoints were not tracked in this imaging-focused analysis.
Exact duration of diagnosed diabetes and chronicity of elevated HbA1c levels were unavailable.
Glycemic status classifications relied solely on HbA1c without oral glucose tolerance testing.
This paper shifts our perspective on how early glycemic dysregulation damages the coronary architecture. Traditional risk models often treat prediabetes as a mild, borderline state, but the imaging data proves that subclinical blood sugar elevations drive morphological vessel changes that closely mirror full-blown diabetes. Finding extended lesion lengths and a high burden of non-calcified plaques in prediabetic patients reveals that vascular remodeling kicks off long before fasting glucose crosses diagnostic clinical lines. Because longer lesion lengths predict higher rates of in-stent restenosis following percutaneous coronary intervention, prediabetic patients likely face an unacknowledged procedural risk that standard risk scores miss.
Translating these findings into nutritional science highlights the urgent need to target postprandial glucose spikes and insulin resistance long before pharmaceutical interventions begin. Whole-food dietary patterns rich in viscous soluble fiber, polyphenols, and micronutrients—such as traditional Mediterranean or plant-forward patterns—play a pivotal role in blunting glycemic variability and mitigating systemic oxidative stress. Chronic hyperinsulinemia and glucose variability fuel the endothelial permeability that allows lipid cores to expand within the arterial wall. Public health guidelines must pivot from merely preventing overt diabetes to aggressively stabilizing blood sugar regulation through unrefined, nutrient-dense dietary patterns that protect endothelial integrity at the earliest possible stage.
Poor glycemic status independently drives the expansion of vulnerable non-calcified plaques and extends coronary lesion length even before diabetes is formally diagnosed. Recognizing this early vascular damage highlights the critical need for aggressive lifestyle and dietary interventions at the prediabetic stage to prevent future cardiovascular events.
r/ScientificNutrition • u/Icy-Performance-5313 • 2d ago
I had multiple questions and was wanting critiques or refutations to the claims promulgated by the raw primal communities and figures such as Aojonus and Goatis.
The first and most obvious claim of the community is that when you cook meat it becomes far less nutritious and they claim raw meat is 90% more nutritious than cooked meat.
Secondly, many of them say vegetables, and grains are anti-human food and humans are not supposed to eat them and lead to health issues, along with tea and coffee. Which they call grain sludge. They also call bread a slave-food.
Thirdly, one of the most astonishing claims from the community is that salt will kill you if you eat it, and it seems idiotic to me but goatis goes down the route of saying "thirty grams will kill you" look how toxic it is... Another thing, they claim water dehydrates you instead of hydrating you and is much inferior to raw milk and or blood, as well as raw meat. Which all have water and will hydrate you. Along with fruits because most of them eat fruit.
Lastly, many of them do seem to have benefits from the diet, as in thicker hair, thicker facial hair, broader shoulders, less mental fog, and more energy. Is this because of the diet? Or other things that they are doing? And in any case, how are they not getting sick?
Thank you for the answers, and sorry for any grammatical errors. English is not my first language.
r/ScientificNutrition • u/tired_dammit • 4d ago
Apologies if this is a common question, I could only find one post on it which had conflicting answers.
When looking into electrolyte mixes I've found there doesn't really seem to be one specific trend between brands for Na:K. It's either an almost equal ratio with just a bit more sodium, or it's something really drastic like 3:1, 5:1. Doesn't matter whether it's specifically labelled/targeted to sport or not, whether it's specific to "hydration" or something else (e.g "wellness", daily nutrition, POTS, whatever) the choice between the two philosophies just seems completely random. What's going on here? Has one strategy been proven to be better over the other, and why? I know you're supposed to lose more sodium in sweat than potassium, but I've also heard differing things about how much the sodium should be balanced out.
r/ScientificNutrition • u/flowersandmtns • 4d ago
Twenty-four studies (20 RCTs, 2 prospective cohorts, 1 non-randomized clinical trial, and 1 pilot intervention; >47,000 participants) were included. Compared with control diets, KD increased low-density lipoprotein cholesterol (LDL-C) (mean difference [MD] + 12.2 mg/dL, 95% CI 7.5 to 16.9; I2 = 67.7%) and total cholesterol, while high-density lipoprotein cholesterol (HDL-C) rose modestly. Triglycerides decreased overall (MD -16.1 mg/dL, 95% CI -20.3 to -11.8; I2 = 17.1%). KD also improved fasting glucose, glycated hemoglobin, body weight, body mass index, and systolic blood pressure. Cohort evidence suggested lower all-cause mortality but no clear reduction in cardiovascular mortality. Imaging evidence for atherosclerosis was limited and mixed.
KD was associated with improvements in adiposity, glycemic control, and blood pressure, but also with higher LDL-C and total cholesterol. Evidence for clinical cardiovascular endpoints remains limited, mixed, and mostly low certainty, supporting individualized risk-benefit assessment rather than universal adoption of KD.
r/ScientificNutrition • u/Evo-DNA • 5d ago
Hi there ~ I am a physician currently working at EvoDNA (evo-dna.com) and I’m curious to know what people think….
Background:
The caffeine gene people talk about is CYP1A2, the liver enzyme that clears most caffeine. A common variant (rs762551) splits people roughly into faster and slower metabolizers.
The study behind most of the hype is Cornelis et al., JAMA 2006: slower metabolizers who drank more coffee had a higher risk of heart attack, while fast metabolizers did not. That's one study population, so it's a reason to pay attention, not a rule.
Practical version:
If coffee keeps you up late, makes you jittery, or raises your blood pressure, you may be on the slower side regardless of what a test says. Your own response is the best data. Cutting caffeine 8+ hours before bed helps most people either way.
Anyone here tested for this?
Did your result match how coffee actually affects you?
Source: Cornelis et al., JAMA 2006
r/ScientificNutrition • u/kasper619 • 6d ago
New University of Cincinnati Cancer Center research found that a ketogenic diet high in long-chain saturated fatty acids can increase inflammation.
Led by Cancer Center Director David Gius, M.D., Ph.D.
**What was the research methodology?**
A ketogenic diet is high in fat and low in carbohydrates, with the goal of entering ketosis, a metabolic state in which the body burns fat and ketones for fuel instead of glucose. While many previous studies have demonstrated anti-inflammatory benefits from a ketogenic diet, other studies have shown increased inflammation and other harmful effects. Gius and colleagues have identified a potential factor contributing to these divergent outcomes.
"We followed the research data while studying a different aspect of ketogenic diets and found something unexpected," said Gius, who also serves as a professor in the Department of Radiation Oncology in UC's College of Medicine and is a UC Health physician. "Our previous studies have found that all ketogenic diets are not the same, with different fats causing different metabolic changes."
In this study, Gius and his team administered ketogenic diets comprising different fatty acids to mouse models and individual fatty acids to tissue culture models.
**What were the results?**
"We found that long-chain saturated fatty acids seem to favor an inflammatory immune response, whereas unsaturated and medium-chain fatty acids tend to favor anti-inflammatory characteristics."
The findings demonstrate that the observed increase in inflammation is mediated through mitochondrial stress signaling and activation of immune cells.
When these findings are combined with those in the team's previous publications in *Science Advances* (2024) and *Cell Reports* (2025), they suggest that multiple factors may need to be considered to achieve the desired outcome on a ketogenic diet, including dietary sources of fat.
In the context of cancer, Gius said ketogenic diets may alter tumor microenvironments in a way that improves immunotherapy treatment outcomes.
A clinical trial is underway at UT Health San Antonio, where Gius began the research, and will open soon at the Cancer Center to learn more.
13 Nov 2026: Sung-Jen Wei et al. ,Ketogenic diets induce proinflammatory macrophage accumulation through long-chain saturated fatty acids driving cGAS-STING signaling.Sci. Adv.12,eaeg5542(2026).DOI:10.1126/sciadv.aeg5542
r/ScientificNutrition
•
u/Dizzy-Savings-1962
•
6d ago
Fermented foods have long enjoyed a reputation for supporting metabolic health, lowering inflammation, and healing a compromised gut barrier, but rigorous clinical proof has remained frustratingly thin. While popular belief holds that live probiotics are the primary engine behind these health perks, modern food manufacturing often relies on pasteurization, which wipes out viable microorganisms while leaving behind dead cellular debris or postbiotics. To settle whether live microbes actually matter for systemic health, researchers launched a randomized crossover trial to test how daily sauerkraut consumption impacts blood pressure, circulating inflammatory markers, glycemic control, and intestinal permeability in healthy adults.
Consuming 100 grams per day of either fresh or pasteurized sauerkraut for four weeks produced a modest, statistically significant reduction in systolic blood pressure of about 1.5 to 2.5 mmHg, proving that live bacteria are not required for that specific hypotensive benefit. Stratifying the data revealed minor improvements in inflammatory markers and glycemic control among younger participants and those following higher-fiber diets, though gut barrier integrity markers remained completely unchanged across the board. Ultimately, daily sauerkraut intake did not trigger sweeping systemic health improvements in healthy individuals, signaling that whole-food fermented products might play a more targeted role or offer greater benefits to metabolically compromised populations rather than healthy cohorts.
Sample Size: 87 healthy participants completed the trial out of 102 randomized individuals.
Duration: Two four-week intervention phases, each preceded by a four-week washout phase with zero fermented food intake.
Intervention: Daily consumption of 100 grams of either fresh sauerkraut (containing active Lacticaseibacillus paracasei) or pasteurized sauerkraut (heated at 75 degrees Celsius for 5 minutes).
Measurement Tools: Fasting blood serum assays for metabolic and inflammatory markers, automatic sphygmomanometers for triplicate blood pressure readings, and validated food frequency questionnaires.
Controls Used: Mixed regression models controlling for sex, age centered at 50 years, baseline BMI centered at 25, and study phase order.
Metabolic Ward: No metabolic ward was used; participants consumed the sauerkraut at home and weighed portions themselves.
Blinding: Unblinded study design due to the visibly distinct textures of fresh and pasteurized sauerkraut.
Washout Period: Yes, two separate four-week washout phases where participants avoided all fermented foods.
Systolic blood pressure decreased significantly by roughly 1.5 to 2.5 mmHg following both fresh and pasteurized sauerkraut interventions.
Participants younger than 50 years old experienced significant reductions in both systolic and diastolic blood pressure after the pasteurized sauerkraut phase.
Fasting blood glucose and fructosamine dropped significantly in younger participants, with pasteurized sauerkraut yielding a more pronounced decrease in long-term blood sugar markers.
High-fiber consumers (30 grams per day or more) experienced a significant decrease in high-sensitivity C-reactive protein (hsCRP) after consuming either sauerkraut type.
Fresh sauerkraut elicited a non-significant hsCRP reduction of -13.2 percent, showing a slightly stronger impact on specific inflammatory proteins compared to its pasteurized counterpart.
Leaky gut markers (FABP-2, zonulin, and lipopolysaccharide-binding protein) showed zero significant changes across any intervention or subgroup.
Small sample size restricted statistical power when breaking data down into multiple demographic strata.
Self-reporting reliance meant researchers could not independently verify exact daily food compliance or home portion weighing accuracy.
Absence of a controlled background diet introduced nutritional confounding factors from varying daily food intake across participants.
Short follow-up duration of four weeks represents the bare minimum for microbiota-targeted interventions and misses long-term health shifts.
High participant drop-out and exclusion rate, driven by schedule conflicts, illnesses, and COVID-19 infections that wiped out individual timepoints.
This trial challenges the dogmatic assumption that live probiotic bacteria are strictly necessary to unlock the cardiovascular benefits of fermented vegetables. Because pasteurized sauerkraut—completely devoid of live colony-forming units—achieved the exact same blood pressure reductions as fresh sauerkraut, non-viable postbiotics, bioactive peptides, organic acids, or mineral content likely drive the hypotensive response. This shifts how nutrition science views food processing, showing that thermal pasteurization does not automatically strip away all physiological utility.
From a public health perspective, these findings temper exaggerated claims about fermented foods acting as a universal cure-all for healthy populations. Because baseline systemic inflammation and gut permeability markers were already normal in this cohort, the intervention had little room to generate dramatic improvements. Future nutritional guidelines and clinical trials should direct focus toward metabolically compromised cohorts, such as individuals battling hypertension, pre-diabetes, or obesity, where baseline dysfunction allows therapeutic whole foods to exert a much more measurable impact.
Both fresh and pasteurized sauerkraut successfully lower systolic blood pressure in healthy adults, proving that live probiotics are not required for this cardiovascular benefit. However, four weeks of daily intake fails to spark broad systemic improvements in inflammatory or gut barrier markers among healthy individuals. Real-world dietary strategies should target populations with pre-existing metabolic strain where functional foods can move the needle.
r/ScientificNutrition • u/misvij • 8d ago
Indian Born American scientist Discovery "Role of Leonlice acid aggregate itching".
r/ScientificNutrition • u/Dizzy-Savings-1962 • 9d ago
DOI: https://doi.org/10.1007/s41999-026-01552-5
PDF link to full study below if you can't access. Here is the downloaded copy:
PDF Link

Higher LDL cholesterol is a well-established risk factor for coronary disease, but studies of older adults have also linked low cholesterol with higher mortality. Evidence from East Asian populations, where average LDL levels are relatively lower, has been limited. This study examined whether low LDL cholesterol was associated with coronary artery disease, stroke, functional disability, and death among 283,289 community-dwelling Japanese adults aged 65–90 years (mean age 72.7 years).
Over a mean 6.3 years, LDL below 80 mg/dL was associated with lower coronary artery disease incidence (adjusted HR 0.56, 95% CI 0.42–0.76; 44% lower hazard) but higher functional disability (HR 1.31, 95% CI 1.26–1.37; 31% higher hazard) and all-cause mortality (HR 1.57, 95% CI 1.50–1.64; 57% higher hazard); all p < 0.001. The combination of LDL below 80 mg/dL and HDL below 40 mg/dL was associated with higher disability (HR 1.46) and mortality (HR 1.85), both p < 0.001. These are observational associations, not evidence that low LDL causes disability or death.
Design: Retrospective observational cohort using the Shizuoka Kokuho Database, which links health-checkup, health-insurance, and long-term-care records.
Sample and follow-up: 283,289 adults aged 65–90; mean follow-up was 6.3 years.
Measurements: LDL and HDL cholesterol and other clinical measures came from annual health checkups. Diagnoses and procedures for coronary disease and stroke, long-term-care certification, and all-cause mortality were identified from administrative records.
Comparison and controls: LDL below 80 mg/dL was the low-LDL category, approximately the lowest 5% of the cohort. Cox models adjusted for age, sex, BMI, smoking, systolic blood pressure, HbA1c, HDL, liver and kidney measures, and urine sugar and protein. Competing-risk analyses accounted for death in analyses of disability and hemorrhagic stroke.
Metabolic ward, blinding, and washout: No metabolic ward or blinding was used, and there was no washout period. This was an observational study with no assigned diet or treatment.
Baseline exclusions: People with prior stroke or coronary disease, hospitalization in the previous 12 months, specified care-level certification, or missing/extreme measurements were excluded.
Low LDL was associated with 44% lower coronary artery disease hazard: HR 0.56 (95% CI 0.42–0.76), p < 0.001. The cohort recorded 1,675 incident coronary artery disease cases.
Low LDL was associated with 31% higher functional-disability hazard: HR 1.31 (95% CI 1.26–1.37), p < 0.001.
Low LDL was associated with 57% higher all-cause mortality hazard: HR 1.57 (95% CI 1.50–1.64), p < 0.001.
Low LDL plus low HDL carried higher hazards: For LDL below 80 mg/dL and HDL below 40 mg/dL, HRs were 1.46 for disability and 1.85 for all-cause mortality; both p < 0.001, compared with participants without either low measurement.
Low HDL alone was also associated with poorer outcomes. About 4.9% of participants had HDL below 40 mg/dL.
The main associations were similar across age and sex subgroups, among participants taking or not taking lipid-lowering medication, and after excluding people with severe baseline comorbidity.
LDL below 100 mg/dL was also associated with disability and mortality. The paper does not report regression coefficients for these findings.
This was an observational study, so residual confounding and reverse causation remain possible. Frailty, poor nutrition, or underlying illness could lower cholesterol while independently raising risks of disability or death.
Health-checkup participation can select a healthier or otherwise different group from the wider older population.
Smoking and medication information came from health-checkup questionnaires; health records and claims can also misclassify diagnoses or outcomes.
Physical activity and socioeconomic factors were not fully controlled, and the analysis did not account for changes in cholesterol or other health measures during follow-up.
Functional disability was identified through care certification, but its underlying cause was not determined.
People leaving the insurance system were censored. The authors assumed this censoring was unrelated to outcomes, but that may not hold in every case; the paper does not report a participant attrition count.
The sample was large, not small. Mean follow-up was 6.3 years, but the study cannot establish long-term causal effects.
This study adds large-scale Japanese data to the debate over the relationship between cholesterol and health in later life. Its central finding is a divergence: low LDL tracked with fewer coronary events, but with more disability and all-cause deaths. That pattern matters because an association between low LDL and mortality in older adults shouldn’t be interpreted as evidence that LDL reduction is harmful. Low cholesterol can accompany frailty or illness, and the study cannot separate those explanations from a direct effect.
The findings don’t test diet. LDL was measured as a clinical marker, not manipulated through food, and the researchers did not compare Mediterranean, plant-forward, or traditional Japanese dietary patterns. They therefore don’t justify changing dietary guidelines or public-health advice to raise LDL. Diet quality still needs to be considered in the broader context of cardiovascular risk and older adults’ nutritional needs, rather than treating one cholesterol measurement as a stand-alone measure of health.
For clinical decisions, the lower coronary disease hazard and higher mortality association need to be considered together, with the important caveat that this cohort cannot show what caused either pattern. The study does not establish that older adults should stop lipid-lowering medication or change their diets. Future work could measure frailty, nutritional status, and dietary intake more directly, track changes in health and cholesterol over time, and test whether the observed pattern differs by treatment or underlying health.
Among older Japanese adults, LDL below 80 mg/dL was associated with fewer coronary events but higher disability and all-cause mortality. These observational findings don’t show that low LDL causes poor outcomes or that raising LDL improves health; more research is needed to distinguish effects of cholesterol from frailty and underlying illness.
r/ScientificNutrition • u/HelenEk7 • 9d ago
From the article:
A new type of software allows anyone to produce ready-to-publish research papers in under two hours. After noting a surge in citations of her work, statistician Andrea Riebler discovered a vendor in China selling a tool that enables rapid paper mining of public health data.
“In our case, we’re talking about software that makes it possible to quickly produce simple, standardised analyses and research papers using public health databases. The analyses may be methodologically sound, but the development is worrying nonetheless,” says Riebler, a statistician at NTNU’s Department of Mathematical Sciences.
The work cannot be properly checked for quality because the authors do not share their source code.
The papers are based on secondary analyses, which presents challenges. The data were originally collected by other researchers, and Riebler questions whether every possible combination of the different types of data available in these databases produces relevant or interesting research.
To read the whole article: https://norwegianscitechnews.com/2026/11/researcher-tracks-explosion-in-citations-to-a-chinese-software/
The article mentions this study:
"Paper mill or paper mine? A tentative answer to the sharp increase in research papers based on the Global Burden of Disease database"
Highlights:
Public health databases are experiencing a sharp increase in formulaic research.
Key drivers include an ecosystem of proprietary resources for rapid paper mining.
Decentralized mass production of papers emerges as a new concern beyond paper mills.
99% of investigated papers fail to share code, obscuring methodological provenance.
Link to the study: https://www.sciencedirect.com/science/article/pii/S0895435626003409
r/ScientificNutrition • u/HelenEk7 • 9d ago
Abstract
Maternal nutrition is a key determinant of fetal development, particularly in the context of neural regulation and maturation. Omega-3 polyunsaturated fatty acids, especially docosahexaenoic acid (DHA), play an essential role in neural differentiation, synaptogenesis, myelination, and neuroprotection. While the neurodevelopmental benefits of DHA are well-documented, the effects of excessive maternal DHA intake and the potential long-term consequences on offspring neurophysiology remain poorly understood. The purpose of this review is to synthesize current findings on the role of DHA in fetal neural development, emphasizing biochemical mechanisms and developmental outcomes. It further explores emerging concerns associated with excessive intake, the varied responses to intake, the varied sources of supplements, and the influence of maternal metabolic conditions, such as diabetes, on DHA bioavailability and fetal brain development. Finally, the review highlights the need for individualized supplementation strategies in maternal nutrition and considers the potential epigenetic implications of prenatal DHA exposure, to ultimately inform future research and therapeutic strategies in maternal–fetal health and neurodevelopmental biology.
r/ScientificNutrition • u/HelenEk7 • 9d ago
ABSTRACT
Background:
Anemia is a major health concern in India, ranking second in maternal mortality and exhibits a higher prevalence compared to many other developing nations. This study aims to analyze prevalence of anemia across age groups using systematic review and meta-analysis.
Methods:
The present systematic review and meta-analysis includes cross-sectional studies from 1995 to 2023, reporting prevalence of anemia in India. Two authors independently screened and extracted data from relevant articles sourced from PubMed, Scopus, and Web of Science. Study quality was assessed using the Newcastle–Ottawa Scale and model selection was based on observed heterogeneity (I2). Geospatial analysis and cumulative meta-analysis were performed using R 4.3.3 and STATA 16 software.
Results:
Across 157 studies, the prevalence of anemia varied among different age groups and regions in India. Toddlers (under 3 years) had a 69% prevalence, with highest in the Eastern (87%) and lowest in the Northern (50%) regions. Pre-school children (3–5 years) had a 64% prevalence, exhibiting 85% and 37% in the Central and the North-Eastern regions, respectively.
Among the school going children, the overall prevalence was 51.2%. The highest prevalence at 83.9% was seen in the North-Eastern regions, while the Central regions had the lowest prevalence at 40%. An overall prevalence of 53% was observed among individuals aged 19–59 years. The Northern region exhibited the highest prevalence (64%) and the lowest in the North-Eastern (39%) regions in this age group. Elderly individuals had a prevalence between 52 to 68%, with the highest in the Eastern (65%) and the lowest in the North-Eastern (44%) regions.
Conclusions:
Anemia prevalence was highest among toddlers and lowest among school children, with notable regional variations. Cumulative meta-analysis uncovered both consistent and increasing trends across various age groups. This meta-analysis provides essential insights for effective strategies against persistence of anemia prevalence.
r/ScientificNutrition • u/HelenEk7 • 9d ago
ABSTRACT
Background: India contributed to 17.3% of the global stillbirth burden in 2019 and anaemia, an important risk factor for stillbirth, affects nearly half of pregnant women in the country. To understand the relationship between maternal anaemia and stillbirth, we analysed a diverse multicohort dataset from the Stillbirth Pooled Indian Cohort Consortium (ICMR-SPIC) from India.
Methods: This was a secondary analysis of the ICMR-SPIC dataset, which includes individual-level data from eight observational studies and two randomised controlled trials conducted across ten states in India. Most cohorts recruited participants between 2010 and 2023, except for the Pune Maternal Nutrition Study (PMNS), which recruited participants between 1994 and 1996. A total of 214,709 singleton pregnant women with known birth outcomes and haemoglobin measurements during pregnancy were included. Unadjusted and adjusted risk ratios for the association between maternal anaemia and stillbirth were estimated using modified Poisson regression for each cohort and pooled using a random-effects meta-analysis. Kaplan-Meier survival curves were estimated for foetal survival beyond 28 weeks of gestation across categories of anaemia severity.
Findings: The median maternal age of the women was 23 years (IQR 21-25). There were 108,982 (52%) women with moderate to severe anaemia (haemoglobin [Hb] <10 g/dL) and 3595 (1.7%) stillbirths. We found that moderate to severe anaemia at any point during pregnancy was associated with a higher risk of stillbirth after 28 weeks of gestation (aRR 1.27, 95% CI 1.07-1.51). The risk ratio for severe anaemia (<7 g/dL) was 3.12 (95% CI 2.46-3.97), and for moderate anaemia it was 1.20 (95% CI 1.02-1.40) at any gestational age, compared to women with no or mild anaemia. We found that stillbirths occurred around the 29th week of gestation among pregnant women with severe anaemia, compared to around 31 weeks of gestation among other women.
Interpretation: These findings highlight that maternal anaemia is an important and potentially modifiable risk factor for stillbirth, with severe anaemia associated with early occurrence of stillbirth. Policies aimed at reducing stillbirths should prioritise comprehensive anaemia prevention and treatment strategies among pregnant women.
r/ScientificNutrition • u/moxyte • 10d ago
There are plenty of studies posted here showing the opposite, that eating more meat leads to worse health outcomes, for example just week ago this one https://www.reddit.com/r/ScientificNutrition/comments/1xmxg1l/meat_consumption_and_risk_of_25_common_conditions/ .
However, the response in the comment section is always the same, where the validity of the result is disagreed with comments painting hypotheticals and whataboutisms that the bad result was caused by some other coefficient, implying no causality or really anything can be ever inferred. Classic example from that thread:
What's a study that fairly represented foods consumption? For any cohort that had questionnaires counting meat-containing junk foods as meat but didn't do the same for junk foods based on soy or whatever, then the data isn't useful regardless of how it's analyzed.
However, discredit is not the same as disprove. That type of sentiment is an attempt at discrediting. In science, actual disprove requires stronger data showing the exact opposite. For example, you may say Newton was an idiot if you disagree with objects falling to ground in order to discredit his research, but to actually disprove Newton you'd have to show objects falling upwards.
This whole meat debate is extremely one-sided like that, where research pumps out studies regularly concluding eating more meat is bad, while the studies showing the opposite simply do not exist as far as I know, as in "the more meat you eat, the less obesity, less cancer, less heart disease, less kidney disease, less diabetes"; actual human health outcomes.
The science is actually settled unless such research exists because if it doesn't exist then the actual number of points of contest is zero, just like in case of objects falling to the ground.
r/ScientificNutrition • u/Main-Dig6441 • 10d ago
If heme iron is essential, I am just wondering why there is no RDA for it.
r/ScientificNutrition • u/Pale-Engineer543 • 10d ago
[you can read it in docs](https://docs.google.com/document/d/19201S9zxb7DjSPTXB1MGgBqKjw271GtS/edit?usp=drivesdk&ouid=103369751575067337640&rtpof=true&sd=true) or here (there might be mistakes as an AI helped create it)
**Research Discussion: Early Childhood Gut Microbiome Development, Food Preferences and the Gut–Brain Axis**
**Purpose:** To share a developing research idea, distinguish existing evidence from open hypotheses, and invite scientific criticism and suggestions.
**Introduction**
I’ve been thinking about a potential research project involving early childhood nutrition, gut microbiome development, food preferences, and communication between the gut and brain.
I have several questions and hypotheses, but I am treating them as ideas to investigate—not as established conclusions. I would appreciate evidence-based feedback, criticism, relevant research papers, and alternative explanations.
Some research already suggests that complementary feeding is an important period for changes in the infant gut microbiome, while repeated exposure to foods can increase acceptance of some flavours. However, the extent to which these processes produce long-term effects, and how they may relate to one another, remains an area for further investigation. \[1–3\]
**A little background about why I’m exploring this**
I’ve been trying to develop a research project that I could realistically carry out during high school. Ideally, I’d like it to be something substantial enough to enter into a science competition, contribute to my academic portfolio, and potentially develop further in university.
However, I’ve repeatedly run into a few problems. Some ideas are too complex to investigate with the resources available to me, others require equipment I don’t have, and some are prohibitively expensive or difficult to complete within a school-year timeframe. Sometimes, I also find gaps in an idea that make it difficult to turn it into a scientifically sound project.
There’s another difficulty I’ve been trying to work through: I don’t want to simplify an interesting research question so much that it loses what made me interested in it in the first place. I tend to become interested in complicated questions with several interacting factors, and reducing them to something very basic can make the project feel disconnected from the original question.
I’m hoping to find a way to preserve the complexity and scientific value of an idea while designing a manageable investigation around it. I’d really appreciate advice on how to approach that, especially from people with experience in microbiome research or developing research projects with limited resources.
I also used AI assistance to help organise and communicate some of these ideas. The research interests and questions are mine, but I wanted help expressing them more clearly.
**1. Early Feeding Experiences and Food Preferences**
I am interested in whether early feeding experiences influence how children perceive and accept foods later in life.
**Questions I would like to investigate:**
Does introducing a variety of flavours and age-appropriate textures during complementary feeding influence a child’s willingness to try unfamiliar foods later?
Can repeated exposure make particular foods more familiar and increase acceptance?
Does the timing and variety of texture exposure influence acceptance of foods with different consistencies as children transition towards family foods?
There is already evidence that repeated taste exposure can increase acceptance of an exposed fruit or vegetable in infants and toddlers. A systematic review found moderate evidence for this effect, while noting that the evidence is more limited for generalising the effect to different food categories and for the transition to more complex textures. \[1, 6\]
**The Breast Milk and Formula Question**
I also wondered whether a familiar milk flavour could influence acceptance of a newly introduced food. For example, could presenting an age-appropriate complementary food alongside a familiar flavour help an infant become more willing to try it?
A related question is whether familiarity with the food’s own flavour develops after repeated exposure, rather than acceptance depending on the familiar milk flavour.
**Questions:**
Could a familiar flavour context influence initial acceptance of an unfamiliar food?
If a food is accepted when presented alongside a familiar flavour, does the child continue accepting it when that flavour is no longer present?
Does repeated exposure to the food itself matter more than the initial familiar flavour association?
Are there differences between flavour exposure through breast milk and exposure through formula?
There is relevant evidence that flavours from a breastfeeding mother’s diet can transfer into breast milk, and that infants can detect some of these flavour changes. However, the systematic review found that evidence was insufficient to draw conclusions about the effect of maternal diet during lactation on children’s overall later dietary intake. This does not establish that mixing milk into complementary foods creates a lasting comfort association, or that gradually reducing the milk proportion would have the proposed effect. Those remain separate questions. \[2\]
I am raising this as a research question, not suggesting that parents change feeding practices or prepare formula differently. Any real-world feeding intervention would need to follow appropriate infant-feeding and food-safety guidance.
**2. Commercially Packaged Baby Food, Texture and Food Preferences**
Another question concerns commercially packaged baby foods, including purees and pouches. I do not assume these products are inherently unhealthy; they can be convenient and may provide useful nutrition. I am interested in whether differences in texture, flavour, ingredients, nutritional composition, and the way food is offered could influence later food acceptance.
**Questions:**
Does frequent exposure to smooth purees, without sufficient progression in texture when developmentally appropriate, affect acceptance of foods that require more chewing?
Does repeated exposure to predominantly sweet fruit flavours influence acceptance of less-sweet flavours?
Does early exposure to a wider range of naturally occurring flavours and textures encourage greater food acceptance?
Do the effects depend more on the food’s nutritional composition, texture, flavour, or feeding method than on whether it is commercially packaged?
**Initial Hypothesis: Familiarity with Processed Food Characteristics**
My initial thought was that repeated exposure to particular food characteristics—such as very smooth textures, sweetness, or a narrow range of flavours—might influence what a child becomes accustomed to eating. I wondered whether this could be related to later preferences for other highly processed foods.
However, I do not know whether there is evidence for a direct relationship between consuming commercial baby food and later preference for ultra-processed foods. I also recognise that ‘processed’ covers many different methods: pureeing, cooking, pasteurising, preserving, and industrial formulation are not interchangeable. I would like to investigate these variables separately rather than assume that processing itself causes a particular preference.
**3. Gut Microbiome Development and the Gut–Brain Axis**
This is the part I am most interested in scientifically. The gut microbiome changes during early childhood, and diet is one of several factors that can influence its composition and function. Complementary feeding coincides with important changes in the infant diet and microbial ecosystem. \[3, 4\]
Communication between the gut and brain is studied as a two-way system involving several pathways, including:
Neural signalling, including the vagus nerve.
Immune signalling and inflammatory pathways.
Hormonal and endocrine signalling.
Microbial metabolites, including short-chain fatty acids and other compounds.
I wonder how early dietary experiences may influence these pathways and whether differences in microbiome development are associated with longer-term health outcomes. Reviews discuss possible links between the gut microbiome and neurodevelopment, but associations do not by themselves show that microbiome differences cause a particular developmental or mental-health outcome. \[4, 5\]
**Research Questions**
Could early dietary diversity influence the composition and function of the developing gut microbiome?
How does complementary feeding influence microbial metabolites and immune development?
Are early microbiome patterns associated with later gut–brain signalling or neurodevelopment?
What evidence exists for relationships between childhood microbiome development and emotional regulation or mental health, and how strong is the evidence for causation?
Could gut–brain or immune pathways influence pain sensitivity in some conditions, and what evidence supports this possibility?
I am interested in whether processes in the gut can contribute to symptoms or responses elsewhere in the body. I do not assume that unexplained pain or other symptoms necessarily originate in the gut. I would like to understand which mechanisms are supported by evidence and which remain speculative.
**4. Potential Practical Application**
I would like the research to have a practical application if the evidence supports one. One possibility could be making nutritious complementary foods more accessible and convenient for parents.
A potential product or approach could prioritise:
A variety of flavours.
Developmentally appropriate textures and safe preparation.
Suitable nutritional composition.
Affordable ingredients and simple preparation.
Practical storage and clear food-safety information.
The aim would not be to eliminate commercial baby food. It would be to explore ways to make varied, nutritious, age-appropriate foods easier for families to access and offer.
**5. Questions for the Scientific Community**
I would especially appreciate feedback on these questions:
What are the strongest studies on early feeding experiences and later food preferences?
Is there research on using familiar flavour cues when introducing complementary foods, and does it show effects beyond initial acceptance?
What is currently known about texture progression and later acceptance of foods with more complex textures?
Is there evidence linking commercial baby food or pouch-feeding patterns with later preferences for ultra-processed foods, after accounting for other factors?
What is currently known about the relationship between complementary feeding, microbiome development, and microbial metabolites?
How strong is the evidence connecting early gut microbiome development with later gut–brain outcomes?
What would be a realistic and ethical way to investigate one of these questions without requiring a long-term study involving infants?
**Conclusion**
I am interested in scientific criticism just as much as supporting evidence. If there are flaws in my reasoning, missing variables, or better ways to frame the questions, I would genuinely like to understand them.
I am still developing this idea, so suggestions for research papers, relevant biological mechanisms, overlooked variables, alternative hypotheses, and feasible experimental approaches would be very welcome.
**Selected Starting References**
These papers and evidence reviews are starting points rather than an exhaustive literature review. I have included them to support the background statements and help guide further discussion.
\[1\] Spill MK, et al. (2019). Repeated exposure to food and food acceptability in infants and toddlers: a systematic review. *The American Journal of Clinical Nutrition*, 109(Suppl 7), 978S–989S. [https://doi.org/10.1093/ajcn/nqy308](https://doi.org/10.1093/ajcn/nqy308)
\[2\] Spahn JM, et al. (2019). Influence of maternal diet on flavor transfer to amniotic fluid and breast milk and children’s responses: a systematic review. *The American Journal of Clinical Nutrition*, 109(Suppl 7), 1003S–1026S. [https://doi.org/10.1093/ajcn/nqy240](https://doi.org/10.1093/ajcn/nqy240)
\[3\] Shi Y, et al. (2024). Impact of complementary feeding on infant gut microbiome, metabolites and early development. *Food & Function*, 15, 10663–10678. [https://doi.org/10.1039/D4FO03948C](https://doi.org/10.1039/D4FO03948C)
\[4\] Catassi G, Aloi M, Giorgio V, Gasbarrini A, Cammarota G, and Ianiro G. (2024). The Role of Diet and Nutritional Interventions for the Infant Gut Microbiome. *Nutrients*, 16(3), 400. [https://doi.org/10.3390/nu16030400](https://doi.org/10.3390/nu16030400)
\[5\] Talat A, Zuberi A, and Khan AU. (2025). Unravelling the Gut-Microbiome-Brain Axis: Implications for Infant Neurodevelopment and Future Therapeutics. *Current Microbiology*, 82(9), 390. [https://doi.org/10.1007/s00284-025-04370-3](https://doi.org/10.1007/s00284-025-04370-3). Review article; interpret proposed clinical implications cautiously.
\[6\] Barends C, et al. (2019). A systematic review of practices to promote vegetable acceptance in the first three years of life. *Appetite*. [https://doi.org/10.1016/j.appet.2019.02.003](https://doi.org/10.1016/j.appet.2019.02.003)
**Note:** This document is a discussion draft. It is not medical advice or a feeding guide. The proposed milk-flavour idea is a research question and should not be treated as a recommendation to alter infant feeding.
Also I’m searching for a mentor, a specialist or a professor who’s interested in guiding me or helping me.
r/ScientificNutrition • u/Doug24 • 11d ago
r/ScientificNutrition • u/biohacker045 • 11d ago
In an 8-week, single-blind randomized controlled trial, 57 adults with overweight consumed 40 grams of milk fat daily, provided as either butter oil or whipping cream. The diets were matched for saturated fat, total calories, protein, carbohydrates, and calcium.
LDL cholesterol rose by 0.36 mmol/L (~14 mg/dL) in the butter group, compared with just 0.04 mmol/L (~2 mg/dL) in the cream group. The difference between groups was statistically significant (P = 0.024), despite equivalent saturated fat intake.
One proposed explanation is the milk fat globule membrane (MFGM), a natural structure rich in phospholipids and sphingolipids that surrounds dairy fat. Cream retains this membrane, while butter-making removes much of it. Separate human research has shown that milk-derived polar lipids can reduce intestinal cholesterol absorption, although the original trial did not establish the precise mechanism behind the LDL difference.
The broader implication: Saturated fat content alone does not necessarily predict how a food will affect LDL cholesterol. The food matrix matters, which may help explain why different foods rich in saturated fat, such as butter, cheese, and yogurt, can produce different cholesterol responses.
Reference: Rosqvist et al., American Journal of Clinical Nutrition, 2015;102(1):20–30
Cardiologist and nutrition researcher Dr. Dariush Mozaffarian discusses this trial and the broader argument for evaluating whole foods rather than isolated nutrients in his new interview with Dr. Rhonda Patrick.
r/ScientificNutrition • u/Material-Ad-3954 • 11d ago
Hey y'all! I'm currently working on my thesis project for my college senior thesis class. I'm doing my project on the relationship between replacing saturated fat with polyunsaturated fat and CVD (cardiovascular disease) risk (though I'm thinking of changing this to CVD combined events risk), CVD mortality, and all-cause mortality. I was wondering if y'all thought there is a proven causal relationship between the reduction of saturated fat in favor of polyunsaturated fat on CVD risk. Observational studies show this association, and we have mechanistic data that aligns with what we see in these studies, but is that enough to prove a causal relationship? Do we need long-term randomized control trials to show a causal association specifically? And does it even matter practically if there is a causal relationship?